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Heartworm in
Canines
Trends in Rhode Island Shelter
Populations
Heartworm
Dirofilaria immitis
  Parasitic roundworm
spread from host to host
via mosquito bite
  Long, slender worms
measuring 20-30 cm
  Live in the pulmonary
artery and the right
ventricle of the heart
  Have life stages in both
the mosquito and dog
http://plpnemweb.ucdavis.edu
Life cycle: D. immitis
  L3 infective stage
  Both larvae and
adults are found in
the body
 Humans can
become dead-end-
hosts
Course of Infection: D. immitis
Vector: D. immitis
  Female mosquito transmits the disease if they are competent and infected
  Over 70 mosquito species have been identified as potential vectors
  Only 9 are prevalent Rhode Island
 Aedes albopictus
 Aedes canadensis
 Aedes cantator
 Aedes excrucians
 Aedes sollicitans
 Aedes taeniorhynchus
 Aedes vexans
 Anopheles punctipennis
 Anopheles quadrimaculatus
http://publichealth.columbus.gov
Testing
 Blood is drawn from cephalic vein
 Only need 3 drops
 Idexx 4Dx SNAP test
 Heartworm
 Ehrlichia canis
 Lyme Disease
 Anaplasmosis phagocytophilium
 Cost: from distributor $16.17
 Average Sharps disposal fee: $5.00
 Any employee wages
http://www.news.cornell.edu/stories/March06/DNABank.kr.html
http://www.idexx.com/view/xhtml/en_us/smallanimal/inhouse/snap/4dx.jsf
Symptoms
 Exercise Intolerance
 Lethargy
 Dry, non-productive cough
 Congestive Heart Failure
 Convulsions
 Vision disturbances
 Liver failure and icterus
http://www.marvistavet.com/html/body_kennel_cough.html
Veterinary Treatment
 Melarsomine split-dosing three-dose protocol-
adulticide
 Combined with Ivermectin- kills microfilaria to
prevent repeated infection
 Often given with a NSAID drug to treat
inflammation in the lungs
 Often given with pain medications- narcotic
analgesics- which also calm and quiet the dog
during treatment
Shelter Treatment
 On average, $300/dog (Humane Society of Hamilton County)
 Often, there is a 4 step process to
treatment
 Find a foster home
 Find a financial benefactor
 Coordinate Treatment
 Find a permanent home http://www.puppyprimer.com/puppy-adoption.html
Shelter Treatment
 Diagnostic, treatment, and prevention protocols for canine
heartworm infection in animal sheltering agencies, Colby et al.,
2011.
 Looked at the shelter protocols in four southern states: AL, FL,
GA, MI
 Up to 90% of admitted dogs in shelters are euthanized in the
south
 Five types of shelter
 Open admissions with a central housing facility
 Limited admissions with a central housing facility
 Foster programs
 Veterinary Clinics that participate in adoption programs
 Sanctuaries
Shelter Treatment
 Of all shelters, only 72% tested all adult dogs, 16% tested some
adult, 12% tested no dogs.
 Most common reason for NOT testing was expense
 Second most common reason for NOT testing was that
treatment was not an option
 Antigen test was the most common testing type (SNAP)
Diagnostic, treatment, and prevention protocols for canine heartworm infection in animal sheltering agencies, Colby
et al., 2011
Shelter Treatment
 Most common outcome for heartworm positive dogs
 Open admissions- adopt/transfer with no treatment,
euthanasia
 Limited admissions- treat and adopt
 Foster- treat and adopt
 Vet clinic- treat and adopt
 Sanctuary- treat and adopt
 Most common treatments for heartworm positive dogs
 Open admissions- No treatment
 Limited admissions- Melarsomine standard two dose protocol
 Foster- Melarsomine split-dosing three-dose protocol
 Vet clinic- Melarsomine split-dosing three-dose protocol
 Sanctuary- Melarsomine standard two dose protocol
Diagnostic, treatment, and prevention protocols for canine heartworm infection in animal sheltering agencies, Colby
et al., 2011
Melarsomine Treatment-
Immiticide® Merial
 Only used to treat adult heartworms
 1 mg/lb body weight
 Given IM over the spine
 3-4 month long process depending on severity of
infection
 Dogs must be kept in strict confinement, as the
dogs can die from a thromboembalism
 Up to 34% of dogs have some form of injection
site reaction (Merial, 2011)
Preventative Measures
 FDA approved heartworm preventatives
 Heartgard® (ivermectin/pyrantel)
 6 mcg/kg
 Chewable tablet
 Give once every 30 days year round
 Interceptor® (milbemycin oxime)
 0.5 mg/kg
 Chewable tablet
 Give once every 30 days year round
 62% of agencies use a monthly preventative, 38% use a
cheaper, livestock preparation of Ivermectin as a preventative
(Colby, et al., 2011)
Resistance to Preventatives
 What is seen as resistance to preventatives by D. immitis
is probably improper dosing of preventatives
 Is anthelmintic resistance a concern for heartworm control? What can
we learn from the human filariasis control programs?, Prichard, R. K.,
2005.
 Unlikely that significant avermectin/milbemycin resistance will
be selected in D. immitis with current treatment strategies
 Evidence suggests several genes can contribute to
avermectin/milbemycin resistance and the mechanisms of
avermectin/milbemycin resistance are complex
US Distribution
 More cases in southeast-
more mosquitoes and
competent species
 Some socio-economic
differences
 Based on reported cases
 Mail survey sent out to
veterinary clinics- unsure
of response rate
Shelter Importation
 Imported dogs account for a large portion of dogs
that test positive.
 2006- 4/7 imported
 1 MA, 1 Puerto Rico, 2 MI
 2007- 1/4 imported
 1 NC
 2008- 0 imported*
 2009- 1/2 imported
 1 GA
 2010- Data on origin of dog not available.
Methods
 Information was provided by three different
shelters across the state of Rhode Island and the
percent is a composite from all of the different
shelters
 Some shelters imported strays from other states
and if the dog originated from another state, that
was indicated in the analysis
 Creating a reservoir for mosquitoes
 Multiple tests for the same dog were not included
D. Immitis Prevalence in RI
Shelters (2006-2010)
Statistical Analyses: D. immitis
Not
significant
with a 95%
CI
Not
significant
with a 95%
CI
Not
significant
with a 95%
CI
Not
significant
with a 95%
CI
Not
significant
with a 95%
CI
Significance
0.1440.7900.4790.7040.144P-Value
2.1320.0710.5010.1442.132Pearson Chi-Square
Statistics
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Comparison to Veterinary Populations
 Prevalence and geographic distribution of Dirofilaria immitis, Borrelia
burgdorferi, Ehrlichia canis, and Anaplasma phagocytophilium in dogs in the
United States: Results of a national clinic-based serologic survey, Bowman et
al., 2008.
 Materials and Methods
 SNAP 3Dx and SNAP 4Dx
 Data was arranged according to residence of the dog
 Results
 2,573 practices submitted samples from over 3 million dogs from all 48 continental
states
 Highest percentage positive samples obtained from the Southeast at 3.9% of all
samples
 Percent of D. immitis infection in RI hospital dogs: 0.8%
 Discussion
 Results agreed with the map of reported cases by American Heartworm Society
Conclusions
 There is no statistical difference between prevalence of
heartworm in shelter and veterinary populations
 Preventative medications, such as
Heartgard® and Interceptor® should be
used on all dogs, year-round in Rhode
Island
 The different treatments for pet dogs v. shelter dogs illustrates
the need for preventative medication, especially for open
admission shelters where euthanasia for heartworm positive
dogs is an option
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